1-112918054-CAATAAATAAATAAATAAATAAATA-CAATA
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_003051.4(SLC16A1):c.362-30_362-11delTATTTATTTATTTATTTATT variant causes a intron change. The variant allele was found at a frequency of 0.00225 in 859,830 control chromosomes in the GnomAD database, including 59 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0019 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0023 ( 59 hom. )
Consequence
SLC16A1
NM_003051.4 intron
NM_003051.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.97
Genes affected
SLC16A1 (HGNC:10922): (solute carrier family 16 member 1) The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 1-112918054-CAATAAATAAATAAATAAATA-C is Benign according to our data. Variant chr1-112918054-CAATAAATAAATAAATAAATA-C is described in ClinVar as [Likely_benign]. Clinvar id is 1629202.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00187 (271/144636) while in subpopulation NFE AF= 0.00209 (139/66424). AF 95% confidence interval is 0.00181. There are 0 homozygotes in gnomad4. There are 121 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 59 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A1 | NM_003051.4 | c.362-30_362-11delTATTTATTTATTTATTTATT | intron_variant | ENST00000369626.8 | NP_003042.3 | |||
SLC16A1 | NM_001166496.2 | c.362-30_362-11delTATTTATTTATTTATTTATT | intron_variant | NP_001159968.1 | ||||
SLC16A1 | XM_047428789.1 | c.362-30_362-11delTATTTATTTATTTATTTATT | intron_variant | XP_047284745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A1 | ENST00000369626.8 | c.362-30_362-11delTATTTATTTATTTATTTATT | intron_variant | 1 | NM_003051.4 | ENSP00000358640.4 |
Frequencies
GnomAD3 genomes AF: 0.00185 AC: 268AN: 144564Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
268
AN:
144564
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00183 AC: 111AN: 60732Hom.: 15 AF XY: 0.00179 AC XY: 64AN XY: 35678
GnomAD3 exomes
AF:
AC:
111
AN:
60732
Hom.:
AF XY:
AC XY:
64
AN XY:
35678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00232 AC: 1662AN: 715194Hom.: 59 AF XY: 0.00235 AC XY: 849AN XY: 362038
GnomAD4 exome
AF:
AC:
1662
AN:
715194
Hom.:
AF XY:
AC XY:
849
AN XY:
362038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00187 AC: 271AN: 144636Hom.: 0 Cov.: 0 AF XY: 0.00172 AC XY: 121AN XY: 70218
GnomAD4 genome
AF:
AC:
271
AN:
144636
Hom.:
Cov.:
0
AF XY:
AC XY:
121
AN XY:
70218
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
SLC16A1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 11, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at